Roche Signs Technology-Transfer Deal With Government-Run Drugmaker

BMI View: With the expansion of public healthcare provision in Brazil, government spending on pharmaceuticals will continue to show robust growth over the next decade. Hospital sales represent a considerable opportunity for pharmaceutical sales growth in Brazil, and we believe that drugmakers that are now investing in strengthening links with the government will improve their chances of securing a long-term presence in the

To read the full article, please choose one of the following options: